McDermott Will & Schulte, a global law firm

Richard B. Smith focuses his practice on representation of life sciences companies and related transactions. He has served as counsel to public, private and emerging life sciences companies, advising those companies on strategic business transactions such as licensing, joint ventures, and collaborations involving research, development, marketing, supply, clinical development and co-promotion of pharmaceutical, diagnostic and medical device products.

See More

• Represented a Dutch biopharmaceutical company in a strategic collaboration with a major pharmaceutical company involving oligonucleotide therapeutic products for an orphan drug indication in a deal valued at more than $650 million
• Represented a publicly held biopharmaceutical company in strategic deals with several major pharmaceutical companies for the development and commercialization of nucleotide-based immune modulators for applications as divers as asthma, allergies and cancer; the transaction related to cancer was publicly valued at more than $500 million

See More